Balanced ETF portfolios USD Q2 2021 commentary

Balanced ETF portfolios USD Q2 2021 commentary

SaxoSelect Commentaries

Saxo Bank

Asset classesStocks (developed and emerging equity), bonds, non-traditional
Investment styleMacro, diversified investment focus
Quarterly return (net of fees) 

Market overview

Similar to the 1st quarter, the 2nd one was characterized by strong economic data. However, after solid performance of risky assets at the beginning of the year, markets have been more muted in the second quarter. In addition, positive data surprises have raised concerns about inflation which could push central banks to lower monetary support and thereby weight on the economic rebound.

The UK and US were leading in terms of positive economic releases – driven by high inoculation rates and fiscal support. The pace of recovery for the European Union has stepped up in Q2 and asset prices benefited. However, in the emerging parts of the world, where vaccination levels are substantially lower, such as in Asia, we have seen new virus outbreaks and lockdowns. 

Not surprisingly, on the equity side, year to date, developed markets reported the highest returns led by Europe, North America and Japan. This was driven by a massive vaccine rollout and strong fiscal and monetary measures. Value and size factor have largely benefitted from these dynamics. The emerging markets, specifically Asia, still returned positively but certainly more muted. The recent increase in infections is part of the story but we should also not forget that these markets posted the strongest quarterly returns over a decade at the end of last year. More recently, China equity has seen a correction which started in February on the back of concerns about policy tightening.

The fixed income markets were clearly influenced by the increase in inflation and, thereby, the fear of tighter monetary policy in the near future. Year to date, government bonds have performed negatively across the board. Climbing up the risk ladder, investment grade still suffered while high yield, as a result of its correlation to equity, managed to post positive returns. Separately, interest rate linked fixed income securities posted low positive returns. 


Portfolio performance

Returns net of feesDefensiveModerateAggressive
Since Inception (Feb 2017)21.4%38.6%52.2%

The multi asset portfolios all produced positive returns in Q2 and YTD, outperforming their respective index benchmarks. 

Broadly speaking, the overweight to equities continues to pay off as the asset class performed strongly. In absolute terms, all equity positions contributed positively led by the US and followed by emerging markets and Europe. From a relative standpoint, since the April rebalance, the overweight to the US, Canada and the emerging markets has contributed. However, an underweight in Europe was a key performance detractor.

The fixed income allocations reflect the general market observations. In absolute terms, contributions were mostly negative with the exception of high yield and interest hedged credit. Long-dated US treasuries were the largest detracting force although the  underweight to duration has helped shielding some of that off. 


Portfolio Allocation and top portfolio holdings (as of June 2021)






The BlackRock team (the “team”) remains optimistic on equity and further increases the equity overweight by funding it from US high yield.

Within the equity sleeve, the team is constructive on EMU as valuation and management sentiment improved. Vaccination rate in major European countries are picking up and improved optimism on a stronger economic recovery. The overweight in Canada is increased because of the country’s exposure to Energy, which is likely to benefit from higher inflation expectation. Also, Canada has made significant progress in vaccinations over the past few weeks. As a result, the share of population that received at least one vaccine dose has surpassed that in UK and US. 

Emerging market equity, US minimum volatility and Pacific ex Japan are the major funding sources for the increase in EMU and Canada. Valuation continued to deteriorate in the emerging markets. It has been lagging in vaccination rates, thereby making it vulnerable to new COVID infection waves and slower economic recovery. Economies in developed markets are expanding on recovery and the Fed’s target zone of low and modest inflation at an average of 2% dimmed performance of minimum volatility. 

Within the fixed income sleeve, the underweight in duration is kept at the portfolio level. US high yield has outperformed the fixed income benchmark and the team is taking profit from the previous overweight as spreads narrowed to the lowest levels in 10 years. The team is moving some of the previous high yield allocation to equity and emerging market fixed income for a higher carry.   

The allocation within the alternative sleeve for all three risk profiles is maintained. 


Any information found in this document, including performance information and statistics are subject to change. You can find the latest updated pricing information on the description page for each available portfolio. In providing this material Saxo Bank has not taken into account any particular recipient’s investment objectives, special investment goals, financial situation, and specific needs and demands and nothing herein is intended as a recommendation for any recipient to invest or divest in a particular manner and Saxo Bank assumes no liability for any recipient sustaining a loss from trading in accordance with a perceived recommendation. All investments entail a risk and may result in both profits and losses, and all capital is at risk. In particular investments in leveraged products, such as but not limited to foreign exchange, derivatives and commodities can be very speculative and profits and losses may fluctuate both violently and rapidly. Speculative trading is not suitable for all investors and all recipients should carefully consider their financial situation and consult financial advisors in order to understand the risks involved and ensure the suitability of their situation prior to making any investment, divestment or entering into any transaction. Any mentioning herein, if any, of any risk may not be, and should not be considered to be, neither a comprehensive disclosure of risks nor a comprehensive description of such risks. Any expression of opinion may not reflect the opinion of Saxo Bank and all expressions of opinion are subject to change without notice (neither prior nor subsequent).

SaxoSelect Balanced Portfolios are offered by Saxo Bank. BlackRock’s data which is utilised by Saxo Bank in building the SaxoSelect Balanced Portfolios is based upon certain internal assumptions and BlackRock has not considered the suitability of the content of its data against individual needs and risk tolerances for all investors. As such, BlackRock’s data is for information purposes only and does not constitute investment advice or an offer to sell or a solicitation of an offer to buy the securities described within. BlackRock’s data has not been prepared in accordance with the legal requirement designed to promote the independence of investment data and is not subject to any prohibition on dealing ahead of the dissemination of the data provided to Saxo Bank and, as such, is considered to be a marketing communication to Saxo Bank. 

iShares and BlackRock are registered trademarks of BlackRock, Inc. and its affiliates (“BlackRock”) and are used under license. BlackRock is not affiliated with Saxo Bank. BlackRock makes no representations or warranties regarding the advisability of investing in any product, portfolio or service offered by Saxo Bank or any of its affiliates. BlackRock has no obligation or liability in connection with the operation, marketing, trading or sale of any product, portfolio or service offered by Saxo Bank or any of its affiliates nor does BlackRock have any obligation or liability to any client or customer of Saxo Bank.

Due to coronavirus controls, we are not able to meet with clients in our reception at present, unless by appointment in exceptional circumstances. We remain at your service on the phone and email details below. Thank you for your understanding.

Please expect very long waiting times on the line when calling us, we advise you to send us an email instead.

Contact Saxo

Select region


Trade responsibly
All trading carries risk. Read more. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more

Saxo Bank A/S is licensed by the Danish Financial Supervisory Authority and operates in the UAE under a representative office license issued by the Central bank of the UAE.

The content and material made available on this website and the linked sites are provided by Saxo Bank A/S. It is the sole responsibility of the recipient to ascertain the terms of and comply with any local laws or regulation to which they are subject.

The UAE Representative Office of Saxo Bank A/S markets the Saxo Bank A/S trading platform and the products offered by Saxo Bank A/S.